Youngmok Park Hyemin Kim Eui-Hyun Kim Chang-Ok Suh Soohyeon Lee
10.4143/crt.2014.165
Cancer Res Treat
2016 Jan;48(1):403-8.
breast neoplasms her2 hypopituitarism neoplasm metastasis
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/25715765/
Breast Neoplasms / metabolism Breast Neoplasms / pathology Hypopituitarism / etiology Pituitary Neoplasms / drug therapy Pituitary Neoplasms / secondary Quinazolines / therapeutic use Receptor, ErbB-2 / metabolism
Breast Neoplasms / metabolism Breast Neoplasms / pathology Hypopituitarism / etiology Pituitary Neoplasms / drug therapy Pituitary Neoplasms / secondary Quinazolines / therapeutic use Receptor, ErbB-2 / metabolism Case Reports Adult Antineoplastic Combined Chemotherapy Protocols / therapeutic use Breast Neoplasms / complications Breast Neoplasms / drug therapy Cyclophosphamide Doxorubicin Female Humans Hypopituitarism / drug therapy Hypopituitarism / pathology Lapatinib Pituitary Neoplasms / complications Pituitary Neoplasms / pathology Trastuzumab / therapeutic use Treatment Outcome Quinazolines Lapatinib Doxorubicin Cyclophosphamide Receptor, ErbB-2 Trastuzumab Combined Pituitary Hormone Deficiency
PMC4720106
25715765
Effective Treatment of Solitary Pituitary Metastasis with Panhypopituitarism in HER2-Positive Breast Cancer by Lapatinib
2016